AFIAS Infliximab tests measures the level of infliximab in blood and provide pharmacokinetic information. It helps to monitor patients with potentially subtherapeutic level and optimize the individual regimen.
AFIAS Infliximab test detects the level of infliximab with a small amount of human serum, plasma, or whole blood in less than 10min. This test provides information regarding the patients’ response towards the treatment of infliximab and based on result physicians can decide the appropriate infliximab regimen.
